Royalty Pharma plc (RPRX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 631M | 621.99M | 609.29M | 578.66M | 568.25M | 593.64M | 564.69M | 537.27M | 567.98M | 596.07M | 536.31M | 538.2M |
| Revenue Growth % | 11.04% | 4.78% | 7.9% | 7.71% | 0.05% | -0.41% | 5.29% | -0.17% | -16.96% | 5.36% | -6.48% | 0.42% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 621.99M | 609.29M | 578.66M | 568.25M | 593.64M | 564.69M | 537.27M | 567.98M | 596.07M | 536.31M | 538.2M |
| Gross Margin % | - | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | -100% | 4.78% | 7.9% | 7.71% | 0.05% | -0.41% | 5.29% | -0.17% | -16.96% | 5.36% | -6.48% | 0.42% |
| Operating Expenses | 199M | 233.61M | 182.13M | 368.87M | 34.06M | 232.13M | -170.38M | 267.64M | 641.75M | -16.83M | 384.87M | 289.36M |
| OpEx % of Revenue | 31.54% | 37.56% | 29.89% | 63.74% | 5.99% | 39.1% | -30.17% | 49.81% | 112.99% | -2.82% | 71.76% | 53.76% |
| Selling, General & Admin | 159M | 164.27M | 118.73M | 179.77M | 110.7M | 67.59M | 56.72M | 54.71M | 57.65M | 59.19M | 57.23M | 47.63M |
| SG&A % of Revenue | 25.2% | 26.41% | 19.49% | 31.07% | 19.48% | 11.39% | 10.04% | 10.18% | 10.15% | 9.93% | 10.67% | 8.85% |
| Research & Development | 40M | 51M | 50.5M | 300.5M | 50.5M | 500K | 500K | 500K | 500K | 500K | 50.5M | 500K |
| R&D % of Revenue | 6.34% | 8.2% | 8.29% | 51.93% | 8.89% | 0.08% | 0.09% | 0.09% | 0.09% | 0.08% | 9.42% | 0.09% |
| Other Operating Expenses | 0 | 1000K | 1000K | -1000K | -1000K | 1000K | -1000K | 1000K | 1000K | -1000K | 1000K | 1000K |
| Operating Income | 563M | 388.38M | 427.16M | 209.8M | 534.18M | 361.51M | 735.07M | 269.63M | -73.77M | 612.9M | 151.44M | 248.84M |
| Operating Margin % | 89.22% | 62.44% | 70.11% | 36.26% | 94.01% | 60.9% | 130.17% | 50.19% | -12.99% | 102.82% | 28.24% | 46.24% |
| Operating Income Growth % | 5.39% | 7.43% | -41.89% | -22.19% | 824.08% | -41.02% | 385.38% | 8.35% | -115.4% | 226.98% | -21.21% | -34.13% |
| EBITDA | 563M | 389.58M | 428.43M | 159.3M | 498.69M | 400.11M | 872.86M | 243.39M | 39.96M | 764.84M | 168.11M | 398.29M |
| EBITDA Margin % | 89.22% | 62.63% | 70.32% | 27.53% | 87.76% | 67.4% | 154.57% | 45.3% | 7.04% | 128.31% | 31.35% | 74% |
| EBITDA Growth % | 12.89% | -2.63% | -50.92% | -34.55% | 1148.01% | -47.69% | 419.22% | -38.89% | -92.81% | 235.83% | -37.13% | -26.05% |
| D&A (Non-Cash Add-back) | 0 | 1.2M | 1.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 0 | 450.08M | 523.77M | 159.3M | 498.69M | 400.11M | 872.86M | 243.39M | 39.96M | 764.84M | 168.11M | 398.29M |
| Net Interest Income | -94M | -87.1M | -72.66M | -60.34M | -53.97M | -56.72M | -49M | -35.63M | -36.81M | -40.76M | -22.6M | -21.3M |
| Interest Income | 0 | 7.07M | 6.9M | 8.33M | 11.29M | 9.04M | 17.51M | 13.38M | 7.42M | 6.5M | 23.44M | 25.65M |
| Interest Expense | 94M | 94.17M | 79.56M | 68.67M | 65.26M | 65.76M | 66.51M | 49.01M | 44.23M | 47.26M | 46.03M | 46.95M |
| Other Income/Expense | -95M | -32.47M | 17.05M | -119.16M | -100.75M | -27.16M | 71.28M | -75.25M | 69.5M | 104.69M | -29.36M | 102.5M |
| Pretax Income | 468M | 355.91M | 444.21M | 90.64M | 433.43M | 334.35M | 806.36M | 194.38M | -4.27M | 717.59M | 122.08M | 351.34M |
| Pretax Margin % | 74.17% | 57.22% | 72.91% | 15.66% | 76.28% | 56.32% | 142.8% | 36.18% | -0.75% | 120.39% | 22.76% | 65.28% |
| Income Tax | 173M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 36.97% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 295M | 214.21M | 288.22M | 30.18M | 238.35M | 208.21M | 543.99M | 102M | 4.78M | 494.34M | 72.11M | 227.63M |
| Net Margin % | 46.75% | 34.44% | 47.3% | 5.21% | 41.94% | 35.07% | 96.33% | 18.99% | 0.84% | 82.93% | 13.45% | 42.29% |
| Net Income Growth % | 23.77% | 2.88% | -47.02% | -70.42% | 4888.47% | -57.88% | 654.34% | -55.19% | -98.6% | 208.39% | -49.45% | -25.25% |
| Net Income (Continuing) | 295M | 355.91M | 444.21M | 90.64M | 433.43M | 334.35M | 806.36M | 194.38M | -4.27M | 717.59M | 122.08M | 351.34M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 3.05B | 3.24B | 3.21B | 3.16B | 3.1B | 3.4B | 3.39B | 3.28B | 3.36B | 3.56B | 3.45B | 3.53B |
| EPS (Diluted) | 0.53 | 0.50 | 0.67 | 0.07 | 0.41 | 0.47 | 1.21 | 0.23 | 0.01 | 1.10 | 0.16 | 0.50 |
| EPS Growth % | 29.27% | 6.38% | -44.63% | -69.57% | 4000% | -57.27% | 656.25% | -54% | -98.68% | 188.71% | -50% | -28.57% |
| EPS (Basic) | 0.68 | 0.64 | 1.05 | 0.09 | 0.55 | 0.47 | 1.22 | 0.23 | 0.01 | 1.48 | 0.21 | 0.51 |
| Diluted Shares Outstanding | 559.61M | 559.61M | 559.61M | 562.3M | 578.1M | 589M | 593M | 596.91M | 597.48M | 602.02M | 601.14M | 605.86M |
| Basic Shares Outstanding | 431.89M | 431.89M | 431.89M | 423.51M | 435.48M | 445.99M | 446.04M | 451.02M | 448.62M | 448.02M | 448.44M | 450.4M |
| Dividend Payout Ratio | 35.42% | 44.04% | 33.07% | 308.99% | 40.01% | 44.98% | 17.29% | 93.08% | 1963.27% | 18.07% | 124.46% | 39.8% |